No Data
Medicae (688079.SH): Shareholder Fengshenjia has collectively reduced their shareholding by 0.9867%.
On February 20, 2025, Meidi Kai (688079.SH) announced that it received a notification from Shareholder Fengsheng Jiamei regarding the expiration of the Shareholding reduction plan and the results of the reduction. As of February 20, 2025, Fengsheng Jiamei reduced its shares by 4,013,333 shares through centralized bidding trading, and reduced 0 shares through block trading, totaling a reduction of 4,013,333 shares, accounting for 0.9867% of the company's total equity. The duration of this Shareholding reduction plan has expired, and the implementation of this Shareholding reduction plan has been completed.
Medicai: Hangzhou Medikai Optoelectronics Technology Co., Ltd. 2024 Annual Results Advance Loss Announcement
Hangzhou Medikai Optoelectronics Technology Co., Ltd. 2024 Annual Results Pre-loss Announcement
Medicare (688079.SH): It is expected to have a net loss of approximately 98.927 million yuan in 2024.
On January 23rd, Gelonghui announced that Meidikai (688079.SH) has reported that (1) according to preliminary calculations by the financial department of Hangzhou Meidikai Optoelectronics Technology Co., Ltd., it is expected to achieve a revenue of about 486.8734 million yuan in 2024, an increase of about 166.1488 million yuan compared to the same period last year, representing a year-on-year increase of approximately 51.80%. (2) It is expected that the net income attributable to the parent company's owners in 2024 will be around -98.927 million yuan. (3) The net income attributed to the parent company's owners, after excluding non-recurring gains and losses, is expected to be around -90.0702 million yuan.
Express News | Medicare: Expected net loss of approximately 98.927 million yuan in 2024.
Express News | Medicare: High-refractive Glass wafers for AR/MR glasses have been mass-produced.